| Name |
Paclitaxel
|
| Supplier |
Biorbyt
|
| Catalog |
orb61089
|
| Prices |
$264.00, $349.00, $391.00, $544.00, $825.00, $1,607.00, $2,831.00
|
| Sizes |
100 mg, 500 mg, 250 mg, 1 g, 2 g, 5 g, 10 g
|
| Cas Number |
[33069-62-4]
|
| Pubchem |
36314
|
| Chemical Name |
(2alpha,4alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-ylbenzoate
|
| Formula |
C47H51NO14
|
| Molecular Weight |
853.91 g/mol
|
| Purity |
>99.5% pure
|
| Description |
Paclitaxel (Taxol, Onxol, Nov-Onxol) is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells. Paclitaxel has entered in a Phase III clinical trial for the treatment of tubular breast cancer stage II, mucinous breast cancer stage II, breast cancer female NOS and invasive ductal breast cancer.
|
| Supplier Page |
Shop
|
